StonvexLoading…
StonvexStonvexStonvexCore line items from KNTK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $409.98M | $1.76B | $1.33B | $870.00M |
Operating Income | $-3.84M | $164.92M | $116.52M | $96.73M |
Net Income | $-1.67M | $178.26M | $35.04M | $29.77M |
EPS (Diluted) | $-0.07 | $2.63 | $0.41 | $0.38 |
Total Assets | $7.11B | $7.10B | $7.20B | $7.15B |
Total Liabilities | $4.27B | $4.17B | $4.58B | $4.34B |
Cash & Equivalents | $720.00K | $3.95M | $7.74M | $10.73M |
Free Cash Flow OCF − CapEx | $97.40M | $111.65M | $135.68M | $104.07M |
Shares Outstanding | 66.68M | 62.66M | 62.12M | 61.69M |